Zika virus vaccine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zika virus vaccine" in English language version.

refsWebsite

Global rank English rank

26nih.gov

4^th place

12doi.org

2^nd place

3clinicaltrials.gov

5,225^th place

4,062^nd place

2web.archive.org

1^st place

1who.int

195^th place

302^nd place

1harvard.edu

18^th place

17^th place

1worldcat.org

5^th place

1wibqam.com

low place

1thelancet.com

2,393^rd place

3,174^th place

clinicaltrials.gov

doi.org

Abbink, P; Stephenson, KE; Barouch, DH (19 June 2018). "Zika virus vaccines". Nature Reviews. Microbiology. 16 (10): 594–600. doi:10.1038/s41579-018-0039-7. PMC 6162149. PMID 29921914.
Fernandez, E; Diamond, MS (19 April 2017). "Vaccination strategies against Zika virus". Current Opinion in Virology. 23: 59–67. doi:10.1016/j.coviro.2017.03.006. PMC 5576498. PMID 28432975.
Barouch, DH; Thomas, SJ; Michael, NL (21 February 2017). "Prospects for a Zika Virus Vaccine". Immunity. 46 (2): 176–182. doi:10.1016/j.immuni.2017.02.005. PMC 5357134. PMID 28228277.
Saiz, JC; Martín-Acebes, MA; Bueno-Marí, R; Salomón, OD; Villamil-Jiménez, LC; Heukelbach, J; Alencar, CH; Armstrong, PK; Ortiga-Carvalho, TM; Mendez-Otero, R; Rosado-de-Castro, PH; Pimentel-Coelho, PM (2017). "Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?". Frontiers in Microbiology. 8: 1554. doi:10.3389/fmicb.2017.01554. PMC 5572254. PMID 28878742.
Priyamvada, L; Hudson, W; Ahmed, R; Wrammert, J (10 May 2017). "Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology". Emerging Microbes & Infections. 6 (5): e33. doi:10.1038/emi.2017.42. PMC 5520485. PMID 28487557.
Ghaffar, KA; Ng, LFP; Renia, L (21 November 2018). "Fast Tracks and Roadblocks for Zika Vaccines". Vaccines. 6 (4): 77. doi:10.3390/vaccines6040077. PMC 6313897. PMID 30469444.
Dowd, KA; Ko, SY; Morabito, KM; Yang, ES; Pelc, RS; DeMaso, CR; Castilho, LR; Abbink, P; Boyd, M; Nityanandam, R; Gordon, DN; Gallagher, JR; Chen, X; Todd, JP; Tsybovsky, Y; Harris, A; Huang, YS; Higgs, S; Vanlandingham, DL; Andersen, H; Lewis, MG; De La Barrera, R; Eckels, KH; Jarman, RG; Nason, MC; Barouch, DH; Roederer, M; Kong, WP; Mascola, JR; Pierson, TC; Graham, BS (14 October 2016). "Rapid development of a DNA vaccine for Zika virus". Science. 354 (6309): 237–240. Bibcode:2016Sci...354..237D. doi:10.1126/science.aai9137. PMC 5304212. PMID 27708058.
Lecouturier, Valérie; Pavot, Vincent; Berry, Catherine; Donadieu, Arnaud; de Montfort, Aymeric; Boudet, Florence; Rokbi, Bachra; Jackson, Nicolas; Heinrichs, Jon (12 March 2020). "An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques". npj Vaccines. 5 (1): 19. doi:10.1038/s41541-020-0167-8. ISSN 2059-0105. PMC 7067768. PMID 32194996.
Fernandez, E; Diamond, MS (19 April 2017). "Vaccination strategies against Zika virus". Current Opinion in Virology. 23: 59–67. doi:10.1016/j.coviro.2017.03.006. PMC 5576498. PMID 28432975.
Baden, LR; Karita, E; Mutua, G; Bekker, LG; Gray, G; Page-Shipp, L; Walsh, SR; Nyombayire, J; Anzala, O; Roux, S; Laher, F; Innes, C; Seaman, MS; Cohen, YZ; Peter, L; Frahm, N; McElrath, MJ; Hayes, P; Swann, E; Grunenberg, N; Grazia-Pau, M; Weijtens, M; Sadoff, J; Dally, L; Lombardo, A; Gilmour, J; Cox, J; Dolin, R; Fast, P; Barouch, DH; Laufer, DS; B003-IPCAVD004-HVTN091 Study, Group. (1 March 2016). "Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial". Annals of Internal Medicine. 164 (5): 313–22. doi:10.7326/M15-0880. PMC 5034222. PMID 26833336.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Hazlewood JE; Tang B; Yan K; Rawle DJ; Harrison JJ; Hall RA; Hobson-Peters J; Suhrbier A (2022). "The Chimeric Binjari-Zika Vaccine Provides Long-Term Protection against ZIKA Virus Challenge". Vaccines. 10 (1): 85. doi:10.3390/vaccines10010085. PMC 8781009. PMID 35062746.

dx.doi.org

Modjarrad, Kayvon; Lin, Leyi; George, Sarah L.; et al. (4 December 2017). "Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomized, double-blind, placebo-controlled clinical trials." The Lancet DOI: https://dx.doi.org/10.1016/S0140-6736(17)33106-9 | Retrieved 14 December 2017.

harvard.edu

ui.adsabs.harvard.edu

Dowd, KA; Ko, SY; Morabito, KM; Yang, ES; Pelc, RS; DeMaso, CR; Castilho, LR; Abbink, P; Boyd, M; Nityanandam, R; Gordon, DN; Gallagher, JR; Chen, X; Todd, JP; Tsybovsky, Y; Harris, A; Huang, YS; Higgs, S; Vanlandingham, DL; Andersen, H; Lewis, MG; De La Barrera, R; Eckels, KH; Jarman, RG; Nason, MC; Barouch, DH; Roederer, M; Kong, WP; Mascola, JR; Pierson, TC; Graham, BS (14 October 2016). "Rapid development of a DNA vaccine for Zika virus". Science. 354 (6309): 237–240. Bibcode:2016Sci...354..237D. doi:10.1126/science.aai9137. PMC 5304212. PMID 27708058.

nih.gov

ncbi.nlm.nih.gov

Abbink, P; Stephenson, KE; Barouch, DH (19 June 2018). "Zika virus vaccines". Nature Reviews. Microbiology. 16 (10): 594–600. doi:10.1038/s41579-018-0039-7. PMC 6162149. PMID 29921914.
Fernandez, E; Diamond, MS (19 April 2017). "Vaccination strategies against Zika virus". Current Opinion in Virology. 23: 59–67. doi:10.1016/j.coviro.2017.03.006. PMC 5576498. PMID 28432975.
Barouch, DH; Thomas, SJ; Michael, NL (21 February 2017). "Prospects for a Zika Virus Vaccine". Immunity. 46 (2): 176–182. doi:10.1016/j.immuni.2017.02.005. PMC 5357134. PMID 28228277.
Saiz, JC; Martín-Acebes, MA; Bueno-Marí, R; Salomón, OD; Villamil-Jiménez, LC; Heukelbach, J; Alencar, CH; Armstrong, PK; Ortiga-Carvalho, TM; Mendez-Otero, R; Rosado-de-Castro, PH; Pimentel-Coelho, PM (2017). "Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?". Frontiers in Microbiology. 8: 1554. doi:10.3389/fmicb.2017.01554. PMC 5572254. PMID 28878742.
Priyamvada, L; Hudson, W; Ahmed, R; Wrammert, J (10 May 2017). "Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology". Emerging Microbes & Infections. 6 (5): e33. doi:10.1038/emi.2017.42. PMC 5520485. PMID 28487557.
Ghaffar, KA; Ng, LFP; Renia, L (21 November 2018). "Fast Tracks and Roadblocks for Zika Vaccines". Vaccines. 6 (4): 77. doi:10.3390/vaccines6040077. PMC 6313897. PMID 30469444.
Dowd, KA; Ko, SY; Morabito, KM; Yang, ES; Pelc, RS; DeMaso, CR; Castilho, LR; Abbink, P; Boyd, M; Nityanandam, R; Gordon, DN; Gallagher, JR; Chen, X; Todd, JP; Tsybovsky, Y; Harris, A; Huang, YS; Higgs, S; Vanlandingham, DL; Andersen, H; Lewis, MG; De La Barrera, R; Eckels, KH; Jarman, RG; Nason, MC; Barouch, DH; Roederer, M; Kong, WP; Mascola, JR; Pierson, TC; Graham, BS (14 October 2016). "Rapid development of a DNA vaccine for Zika virus". Science. 354 (6309): 237–240. Bibcode:2016Sci...354..237D. doi:10.1126/science.aai9137. PMC 5304212. PMID 27708058.
Lecouturier, Valérie; Pavot, Vincent; Berry, Catherine; Donadieu, Arnaud; de Montfort, Aymeric; Boudet, Florence; Rokbi, Bachra; Jackson, Nicolas; Heinrichs, Jon (12 March 2020). "An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques". npj Vaccines. 5 (1): 19. doi:10.1038/s41541-020-0167-8. ISSN 2059-0105. PMC 7067768. PMID 32194996.
Fernandez, E; Diamond, MS (19 April 2017). "Vaccination strategies against Zika virus". Current Opinion in Virology. 23: 59–67. doi:10.1016/j.coviro.2017.03.006. PMC 5576498. PMID 28432975.
Baden, LR; Karita, E; Mutua, G; Bekker, LG; Gray, G; Page-Shipp, L; Walsh, SR; Nyombayire, J; Anzala, O; Roux, S; Laher, F; Innes, C; Seaman, MS; Cohen, YZ; Peter, L; Frahm, N; McElrath, MJ; Hayes, P; Swann, E; Grunenberg, N; Grazia-Pau, M; Weijtens, M; Sadoff, J; Dally, L; Lombardo, A; Gilmour, J; Cox, J; Dolin, R; Fast, P; Barouch, DH; Laufer, DS; B003-IPCAVD004-HVTN091 Study, Group. (1 March 2016). "Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial". Annals of Internal Medicine. 164 (5): 313–22. doi:10.7326/M15-0880. PMC 5034222. PMID 26833336.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Hazlewood JE; Tang B; Yan K; Rawle DJ; Harrison JJ; Hall RA; Hobson-Peters J; Suhrbier A (2022). "The Chimeric Binjari-Zika Vaccine Provides Long-Term Protection against ZIKA Virus Challenge". Vaccines. 10 (1): 85. doi:10.3390/vaccines10010085. PMC 8781009. PMID 35062746.

pubmed.ncbi.nlm.nih.gov

Abbink, P; Stephenson, KE; Barouch, DH (19 June 2018). "Zika virus vaccines". Nature Reviews. Microbiology. 16 (10): 594–600. doi:10.1038/s41579-018-0039-7. PMC 6162149. PMID 29921914.
Fernandez, E; Diamond, MS (19 April 2017). "Vaccination strategies against Zika virus". Current Opinion in Virology. 23: 59–67. doi:10.1016/j.coviro.2017.03.006. PMC 5576498. PMID 28432975.
Barouch, DH; Thomas, SJ; Michael, NL (21 February 2017). "Prospects for a Zika Virus Vaccine". Immunity. 46 (2): 176–182. doi:10.1016/j.immuni.2017.02.005. PMC 5357134. PMID 28228277.
Saiz, JC; Martín-Acebes, MA; Bueno-Marí, R; Salomón, OD; Villamil-Jiménez, LC; Heukelbach, J; Alencar, CH; Armstrong, PK; Ortiga-Carvalho, TM; Mendez-Otero, R; Rosado-de-Castro, PH; Pimentel-Coelho, PM (2017). "Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?". Frontiers in Microbiology. 8: 1554. doi:10.3389/fmicb.2017.01554. PMC 5572254. PMID 28878742.
Priyamvada, L; Hudson, W; Ahmed, R; Wrammert, J (10 May 2017). "Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology". Emerging Microbes & Infections. 6 (5): e33. doi:10.1038/emi.2017.42. PMC 5520485. PMID 28487557.
Ghaffar, KA; Ng, LFP; Renia, L (21 November 2018). "Fast Tracks and Roadblocks for Zika Vaccines". Vaccines. 6 (4): 77. doi:10.3390/vaccines6040077. PMC 6313897. PMID 30469444.
Dowd, KA; Ko, SY; Morabito, KM; Yang, ES; Pelc, RS; DeMaso, CR; Castilho, LR; Abbink, P; Boyd, M; Nityanandam, R; Gordon, DN; Gallagher, JR; Chen, X; Todd, JP; Tsybovsky, Y; Harris, A; Huang, YS; Higgs, S; Vanlandingham, DL; Andersen, H; Lewis, MG; De La Barrera, R; Eckels, KH; Jarman, RG; Nason, MC; Barouch, DH; Roederer, M; Kong, WP; Mascola, JR; Pierson, TC; Graham, BS (14 October 2016). "Rapid development of a DNA vaccine for Zika virus". Science. 354 (6309): 237–240. Bibcode:2016Sci...354..237D. doi:10.1126/science.aai9137. PMC 5304212. PMID 27708058.
Lecouturier, Valérie; Pavot, Vincent; Berry, Catherine; Donadieu, Arnaud; de Montfort, Aymeric; Boudet, Florence; Rokbi, Bachra; Jackson, Nicolas; Heinrichs, Jon (12 March 2020). "An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques". npj Vaccines. 5 (1): 19. doi:10.1038/s41541-020-0167-8. ISSN 2059-0105. PMC 7067768. PMID 32194996.
Fernandez, E; Diamond, MS (19 April 2017). "Vaccination strategies against Zika virus". Current Opinion in Virology. 23: 59–67. doi:10.1016/j.coviro.2017.03.006. PMC 5576498. PMID 28432975.
Baden, LR; Karita, E; Mutua, G; Bekker, LG; Gray, G; Page-Shipp, L; Walsh, SR; Nyombayire, J; Anzala, O; Roux, S; Laher, F; Innes, C; Seaman, MS; Cohen, YZ; Peter, L; Frahm, N; McElrath, MJ; Hayes, P; Swann, E; Grunenberg, N; Grazia-Pau, M; Weijtens, M; Sadoff, J; Dally, L; Lombardo, A; Gilmour, J; Cox, J; Dolin, R; Fast, P; Barouch, DH; Laufer, DS; B003-IPCAVD004-HVTN091 Study, Group. (1 March 2016). "Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial". Annals of Internal Medicine. 164 (5): 313–22. doi:10.7326/M15-0880. PMC 5034222. PMID 26833336.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Hazlewood JE; Tang B; Yan K; Rawle DJ; Harrison JJ; Hall RA; Hobson-Peters J; Suhrbier A (2022). "The Chimeric Binjari-Zika Vaccine Provides Long-Term Protection against ZIKA Virus Challenge". Vaccines. 10 (1): 85. doi:10.3390/vaccines10010085. PMC 8781009. PMID 35062746.

niaid.nih.gov

"Zika Virus Vaccines | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov. 16 August 2018.
"Phase 2 Zika Vaccine Trial Begins in U.S., Central and South America | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov.
"Testing of Investigational Inactivated Zika Vaccine in Humans Begins | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov.
"Zika Virus Vaccines | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov. 16 August 2018.

thelancet.com

Modjarrad, Kayvon; Lin, Leyi; George, Sarah L.; et al. (4 December 2017). "Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomized, double-blind, placebo-controlled clinical trials." The Lancet DOI: https://dx.doi.org/10.1016/S0140-6736(17)33106-9 | Retrieved 14 December 2017.

web.archive.org

"Zika virus vaccine product development". World Health Organization. Archived from the original on July 19, 2016.
Reuters. Steenhuysen, Julie and Chang, Richard. (4 December 2017). "Trial results of Zika vaccine Sanofi dropped show promise". WIBQ website Archived 2019-06-17 at the Wayback Machine Retrieved 13 December 2017.

who.int

"Zika virus vaccine product development". World Health Organization. Archived from the original on July 19, 2016.

wibqam.com

Reuters. Steenhuysen, Julie and Chang, Richard. (4 December 2017). "Trial results of Zika vaccine Sanofi dropped show promise". WIBQ website Archived 2019-06-17 at the Wayback Machine Retrieved 13 December 2017.

worldcat.org

search.worldcat.org

Lecouturier, Valérie; Pavot, Vincent; Berry, Catherine; Donadieu, Arnaud; de Montfort, Aymeric; Boudet, Florence; Rokbi, Bachra; Jackson, Nicolas; Heinrichs, Jon (12 March 2020). "An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques". npj Vaccines. 5 (1): 19. doi:10.1038/s41541-020-0167-8. ISSN 2059-0105. PMC 7067768. PMID 32194996.